Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon

[1]  Nafisur Rahman,et al.  Analytical techniques in pharmaceutical analysis: A review , 2017 .

[2]  S. Pastakia,et al.  The Revolving Fund Pharmacy Model: backing up the Ministry of Health supply chain in western Kenya , 2016, The International journal of pharmacy practice.

[3]  C. Masimirembwa,et al.  Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects? , 2016, Omics : a journal of integrative biology.

[4]  A. Goga,et al.  Enhancing HIV Treatment Access and Outcomes Amongst HIV Infected Children and Adolescents in Resource Limited Settings , 2016, Maternal and Child Health Journal.

[5]  K. du Toit,et al.  Patents and the quality, safety and efficacy of medicines. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  A. Kamali,et al.  Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design , 2015, Contemporary clinical trials.

[7]  Matthew E. Falagas,et al.  Substandard/Counterfeit Antimicrobial Drugs , 2015, Clinical Microbiology Reviews.

[8]  D. Pillay,et al.  Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. , 2014, The lancet. HIV.

[9]  H. Sillo,et al.  Regulatory Framework for Access to Safe, Effective Quality Medicines , 2014, Antiviral therapy.

[10]  L. Bekker,et al.  Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts , 2014, Antiviral therapy.

[11]  Atholl Johnston,et al.  Substandard drugs: a potential crisis for public health , 2013, British journal of clinical pharmacology.

[12]  B. Taye,et al.  Assessment of laboratory logistics management information system practice for HIV/AIDS and tuberculosis laboratory commodities in selected public health facilities in Addis Ababa, Ethiopia , 2013, The Pan African medical journal.

[13]  L. Gostin,et al.  COMMITTEE ON UNDERSTANDING THE GLOBAL PUBLIC HEALTH IMPLICATIONS OF SUBSTANDARD, FALSIFIED, AND COUNTERFEIT MEDICAL PRODUCTS , 2013 .

[14]  L. Gostin,et al.  The Effects of Falsified and Substandard Drugs , 2013 .

[15]  E. Abrams,et al.  Decentralization of Pediatric HIV Care and Treatment in Five Sub-Saharan African Countries , 2013, Journal of acquired immune deficiency syndromes.

[16]  L. Kuhn,et al.  Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa , 2013, AIDS.

[17]  O. Oguntibeju.  Quality of life of people living with HIV and AIDS and antiretroviral therapy , 2012, HIV/AIDS.

[18]  R. Heyderman,et al.  Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi , 2012, PloS one.

[19]  D. de Savigny,et al.  Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening , 2011, Globalization and health.

[20]  Lucy Gilson,et al.  Health Systems and Access to Antiretroviral Drugs for HIV in Southern Africa: Service Delivery and Human Resources Challenges , 2006, Reproductive health matters.

[21]  H. Masur,et al.  Antiretroviral drug content in products from developing countries. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  H. Masur,et al.  Analysis of generic nevirapine products in developing countries. , 2003, JAMA.

[23]  J. James.  Counterfit drugs: check Combivir, Serostim, Epogen. , 2002, AIDS treatment news.

[24]  Ellen t'Hoen.  Assuring access to quality antiretroviral medicines: the WHO Prequalification of Medicines Program and access to HIV treatment. , 2014, Cadernos de Saúde Pública.

[25]  J. Pinto,et al.  Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. , 2007, Cadernos de saude publica.

[26]  V. Arendt,et al.  HPLC analysis of generic antiretroviral drugs purchased in Rwanda. , 2005, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg.